ID   Nips-B2
AC   CVCL_T775
SY   iPS-B2; HPS0223
DR   RCB; HPS0223
DR   SKIP; SKIP000266
DR   Wikidata; Q54930614
RX   PubMed=22912751;
RX   PubMed=26199952;
RX   PubMed=32996421;
CC   Population: Japanese.
CC   Derived from site: In situ; Nose, nasal cavity, epithelium; UBERON=UBERON_0005384.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
RX   PubMed=22912751; DOI=10.1371/journal.pone.0042855;
RA   Ono M., Hamada Y., Horiuchi Y., Matsuo-Takasaki M., Imoto Y.,
RA   Satomi K., Arinami T., Hasegawa M., Fujioka T., Nakamura Y.,
RA   Noguchi E.;
RT   "Generation of induced pluripotent stem cells from human nasal
RT   epithelial cells using a Sendai virus vector.";
RL   PLoS ONE 7:E42855-E42855(2012).
//
RX   PubMed=26199952; DOI=10.1038/mtm.2015.23;
RA   Sato Y., Kobayashi H., Higuchi T., Shimada Y., Era T., Kimura S.,
RA   Eto Y., Ida H., Ohashi T.;
RT   "Disease modeling and lentiviral gene transfer in patient-specific
RT   induced pluripotent stem cells from late-onset Pompe disease
RT   patient.";
RL   Mol. Ther. Methods Clin. Dev. 2:15023-15023(2015).
//
RX   PubMed=32996421; DOI=10.1177/1010428320962588;
RA   Watanabe K., Nakamura T., Onodera S., Saito A., Shibahara T.,
RA   Azuma T.;
RT   "A novel GNAS-mutated human induced pluripotent stem cell model for
RT   understanding GNAS-mutated tumors.";
RL   Tumor Biol. 42:1010428320962588-1010428320962588(2020).
//